Adverse Events, Comorbidities, and HIV

The Latest

invisible ink

This Week in HIV Research: Missing the Message

May 13, 2021: Disparities in U=U awareness; sexual satisfaction trends among PLWH; PrEP use among cis women; HCV epidemiology in trans women.

By Barbara Jungwirth and Myles Helfand
birthday candles

This Week in HIV Research: Getting Wiser About Getting Older

May 6, 2021: Epigenetic aging and HIV treatment initiation; effects of ART on cognitive decline; dearth of osteoporosis screenings for PLWH; physical therapy vs. opioids for bone/muscle pain.

By Barbara Jungwirth and Myles Helfand
Hepatitis C

The Silent Killer: Expanding Hepatitis C Testing and Treatment Saves Lives and Money

Studies show increasing access to screening can go a long way in reaching people at higher risk for HCV.

By Juan Michael Porter II
TracySwann-1000x667 ITPC

“This Information Will Be Useful in the Future”: How a Tuberculosis Toolkit Became a COVID-19 Timeline

A newly launched chronology traces the unfolding pandemic and the consequences of economic and political decisions around the world.

By Terri Wilder, M.S.W.
nose closeup

A Smell Test May Help Disentangle Alzheimer’s From HIV-Associated Neurocognitive Disorder

A study suggests olfactory function may be a useful tool in distinguishing between HAND and a precursor for Alzheimer’s disease in older people living with HIV.

By Michael Broder
weights and measures

This Week in HIV Research: Weights and Measures

April 22, 2021: Weight gain and CVD risk after treatment initiation; stroke type divergence among PLWH; exercise and CD4; a new approach to pain research in HIV.

By Barbara Jungwirth and Myles Helfand
empty shot

This Week in HIV Research: The Complexities of Alcohol and Substance Use

April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.

By Barbara Jungwirth and Myles Helfand
David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
thumbnail CITY Jeremy Tjhung-25033

Most Cancer Drug Trials Still Exclude People With HIV. That’s Both Unfounded and Dangerous.

Helping my longtime friend Jeremy find such trials alerted me to this ongoing problem—which will only be reversed if patients, doctors, and trial reviewers keep pushing back on Pharma.

By Tim Murphy
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.